Purdue Pharma asserts patent infringement claims under Hatch-Waxman Act related to OxyContin® against Abhai
Client(s) Purdue Pharma L.P.
Jones Day successfully represented Purdue Pharma L.P. in a Hatch-Waxman patent infringement action against the defendant, Abhai LLC's, submission of an Abbreviated New Drug Application to the FDA seeking approval of generic versions of OxyContin®, a widely prescribed drug for pain relief.
Purdue Pharma LP et al. v. Abhai LLC et al., No. 1-17-cv-00450 (D. Del.)
